stella
beta
A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes — Stella
Recruiting
Back to Diabetes Mellitus, Type 1 trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Shanghai Changzheng Hospital, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov